Sitemap 14
Sitemap 15
Sitemap 16
Sitemap 17
Sitemap 18
Sitemap 19
Sitemap 20
Sitemap 21
Sitemap 22
Sitemap 23
Sitemap 24
Sitemap 25
Sitemap 26
Sitemap 27
Sitemap 28
Sitemap 29
Sitemap 30
Sitemap 31

U.S. Department of Defense Invests In Prostrate Cancer Treatment

The U.S. Department of Defense/Prostrate Cancer Research Program (DoD/PCRP) gave a grant of just over $1.5 million dollars to SRI International to support pre-clinical studies of the non-profit organization’s agents that might be able to develop into drugs to treat prostate cancer. This grant follows an earlier one that had led to some positive results utilizing plant products.

The U.S. defense budget contains a great deal of novel R&D efforts and a lot of funding. Congress has used it to fund breast and other cancer and disease prevention and treatment research. Obviously the military has a great deal invested in their human capital and medical treatment and this funding helps in those areas. SRI International is a spin-off of Stanford University specializing in sponsored research for government, businesses and foundations.

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter

>